ANI PHARMACEUTICALS INC. - COMMON STOCK
61.31
06-June-25 11:22:30
15 minutes delayed
Stocks
+1.43
+2.38%
Today's range
59.89 - 61.46
ISIN
N/A
Source
NASDAQ
-
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
23 Jan 2024 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
16 Jan 2024 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
22 Nov 2023 06:26:49 By Nasdaq GlobeNewswire
-
08 Nov 2023 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
30 Oct 2023 03:50:00 By Nasdaq GlobeNewswire
-
25 Oct 2023 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
18 Sep 2023 13:05:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
12 Sep 2023 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
28 Aug 2023 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
24 Aug 2023 03:50:00 By Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
23 Aug 2023 03:50:00 By Nasdaq GlobeNewswire
-
09 Aug 2023 03:50:31 By Nasdaq GlobeNewswire
-
31 Jul 2023 04:17:19 By Nasdaq GlobeNewswire